Cyclacel Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK…

Biotechnology
US, Berkeley Heights [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CYCC's Analysis
CIK: 1130166 CUSIP: 23254L603 ISIN: US23254L8019 LEI: - UEI: -
Secondary Listings
CYCC has no secondary listings inside our databases.